It's not pretty! There is a lot riding on these "next-gen products" and getting past the manufacturing problem and lawsuit. Remedi could help plug the revenue gap but they need to show growth and rollout numbers, not failure to convert the MoU into an agreement.
Ann: BDT H1 FY24 Results Announcement, page-6
Add BDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.89M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6250 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 90000 | 1 |
View Market Depth
| Last trade - 16.12pm 17/06/2024 (20 minute delay) ? |
| BDT (ASX) Chart |
Day chart unavailable
